1. Home
  2. EVAX vs TRIB Comparison

EVAX vs TRIB Comparison

Compare EVAX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • TRIB
  • Stock Information
  • Founded
  • EVAX 2008
  • TRIB 1992
  • Country
  • EVAX Denmark
  • TRIB Ireland
  • Employees
  • EVAX N/A
  • TRIB N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • EVAX Health Care
  • TRIB Health Care
  • Exchange
  • EVAX Nasdaq
  • TRIB Nasdaq
  • Market Cap
  • EVAX 10.8M
  • TRIB 12.5M
  • IPO Year
  • EVAX 2021
  • TRIB N/A
  • Fundamental
  • Price
  • EVAX $3.13
  • TRIB $0.65
  • Analyst Decision
  • EVAX Strong Buy
  • TRIB
  • Analyst Count
  • EVAX 2
  • TRIB 0
  • Target Price
  • EVAX $10.00
  • TRIB N/A
  • AVG Volume (30 Days)
  • EVAX 134.8K
  • TRIB 61.0K
  • Earning Date
  • EVAX 05-27-2025
  • TRIB 06-17-2025
  • Dividend Yield
  • EVAX N/A
  • TRIB N/A
  • EPS Growth
  • EVAX N/A
  • TRIB N/A
  • EPS
  • EVAX N/A
  • TRIB N/A
  • Revenue
  • EVAX $3,293,000.00
  • TRIB $61,555,000.00
  • Revenue This Year
  • EVAX N/A
  • TRIB $13.51
  • Revenue Next Year
  • EVAX N/A
  • TRIB $13.14
  • P/E Ratio
  • EVAX N/A
  • TRIB N/A
  • Revenue Growth
  • EVAX 2555.64
  • TRIB 8.31
  • 52 Week Low
  • EVAX $1.20
  • TRIB $0.48
  • 52 Week High
  • EVAX $19.95
  • TRIB $3.55
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 75.25
  • TRIB 42.17
  • Support Level
  • EVAX $2.58
  • TRIB $0.63
  • Resistance Level
  • EVAX $2.84
  • TRIB $0.68
  • Average True Range (ATR)
  • EVAX 0.25
  • TRIB 0.05
  • MACD
  • EVAX 0.10
  • TRIB -0.01
  • Stochastic Oscillator
  • EVAX 96.79
  • TRIB 7.77

About EVAX Evaxion Biotech

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: